Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Sinigaglia

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
La Medicina Del Lavoro|November 19, 2003
[Sister chromatid exchange (SCE)and high-frequency cells in workers professionally exposed to extremely low-frequency magnetic fields (ELF)]F Gobba, L Roccatto, Barbara Sinigaglia, et al.
Cancer Genetics and Cytogenetics|March 24, 2004
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemiaLeonardo Potenza, Barbara Sinigaglia, Mario Luppi, et al.
Transplantation and Cellular Therapy|February 16, 2023
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell TransplantationGabriella Chirumbolo, Michele Dicataldo, Martina Barone, et al.
Frontiers in Oncology|August 22, 2022
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitorsManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Mediators of Inflammation|August 18, 2018
Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34<sup>+</sup> CellsDorian Forte, Daria Sollazzo, Martina Barone, et al.
European Journal of Medical Genetics|September 2, 2008
Mild mental retardation in a child with a de novo interstitial deletion of 15q21.2q22.1: a comparison with previously described casesSergio Tempesta, Danila Sollima, Sara Ghezzo, et al.
Bone Marrow Transplantation|June 10, 2021
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomasFrancesca Bonifazi, Irene Defrancesco, Jacopo Olivieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2018
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic SyndromesFrancesca Bonifazi, Jacopo Olivieri, Mariarosaria Sessa, et al.
Bone Marrow Transplantation|September 21, 2018
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyFrancesca Bonifazi, Elisa Dan, Myriam Labopin, et al.
Bone Marrow Transplantation|September 24, 2025
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipientsDavide Leardini, Marcello Roberto, Sara Roggiani, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
La Medicina Del Lavoro|November 19, 2003
[Sister chromatid exchange (SCE)and high-frequency cells in workers professionally exposed to extremely low-frequency magnetic fields (ELF)]F Gobba, L Roccatto, Barbara Sinigaglia, et al.
Cancer Genetics and Cytogenetics|March 24, 2004
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemiaLeonardo Potenza, Barbara Sinigaglia, Mario Luppi, et al.
Transplantation and Cellular Therapy|February 16, 2023
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell TransplantationGabriella Chirumbolo, Michele Dicataldo, Martina Barone, et al.
Frontiers in Oncology|August 22, 2022
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitorsManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Mediators of Inflammation|August 18, 2018
Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34<sup>+</sup> CellsDorian Forte, Daria Sollazzo, Martina Barone, et al.
European Journal of Medical Genetics|September 2, 2008
Mild mental retardation in a child with a de novo interstitial deletion of 15q21.2q22.1: a comparison with previously described casesSergio Tempesta, Danila Sollima, Sara Ghezzo, et al.
Bone Marrow Transplantation|June 10, 2021
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomasFrancesca Bonifazi, Irene Defrancesco, Jacopo Olivieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2018
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic SyndromesFrancesca Bonifazi, Jacopo Olivieri, Mariarosaria Sessa, et al.
Bone Marrow Transplantation|September 21, 2018
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyFrancesca Bonifazi, Elisa Dan, Myriam Labopin, et al.
Bone Marrow Transplantation|September 24, 2025
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipientsDavide Leardini, Marcello Roberto, Sara Roggiani, et al.
Pageof 3